National Bankshares Inc. (VA) (NKSH) is Trading Lower on Unusual Volume for January 04

Equities Staff |

National Bankshares Inc. (VA) (NKSH) experienced unusually high volume on Jan. 04, as the stock lost 4.9% to a closing price of $33.80. The stock saw 25,279 shares trade hands over the course of the day on 302 trades. Given that the stock’s average daily volume over the last month has been 9,561 shares a day, this represents a pretty substantial spike over the norm.

National Bankshares Inc. (VA) has a P/B ratio of 1.35. It also has a P/E ratio of 15.1. The stock has traded between $36.76 and $27.48 over the last 52-weeks, its 50-day SMA is now $34.95, and its 200-day SMA $30.91.

National Bankshares Inc is a bank holding company. It provides retail and commercial banking services such as deposit accounts, commercial, consumer and mortgage loans, credit cards and trust services.

Headquartered in Blacksburg, VA, National Bankshares Inc. (VA) has 217 employees and is currently under the leadership of CEO F. Brad Denardo / James G. Rakes.

For a complete fundamental analysis analysis of National Bankshares Inc. (VA), check out’s Stock Valuation Analysis report for NKSH. To see the latest independent stock recommendations from’s analysts, visit our Research section.


The Russell 3000 is not well known outside the world of finance, but it’s one of the strongest indices out there for getting a broad sense of the stock market. Unlike the better-known Dow Jones Industrial Average or S&P 500, membership on the Russell 3000 isn’t selected by committee. It’s simply the 3,000 most valuable companies in the country.

With 3,000 stocks making up the index, it gives a broad look at the markets, including the small-and mid-cap companies that aren’t on the Dow or the S&P 500. And with a rules-based system for determining membership, there’s no bias that could potentially limit membership. That’s why many financial professionals will turn to the Russell 3000 long before the better-known indices when trying to take the temperature of the market.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets

CF0005, LLC dba Mesa-Marshall #1-2

MESA Resources, Inc. ("MESA") is sponsoring the development of the oil & gas well completion project "Mesa-Marshall #1-2". MESA, founded in 1992, is engaged in the acquisition, exploration and development…

Quants Inc

Quants, Inc, a California Corporation, develops, markets and operates financial technology platforms and alternative investment products offering sophisticated risk management since 2010. The Company has primarily sharpened its focus with…